Recent Company News

• 07:38 AM ET Jun 06, 2025
  

  Energy, Healthcare and Retail lead; Basic Resources, Industrial Goods/Services and Consumer Products/Services lag:

• 02:40 AM ET Jun 06, 2025
  

  Sandoz Group downgraded to hold from buy at Vontobel (CHF 43.79, 0.00)

• 01:02 AM ET Jun 02, 2025
  

  Sandoz Group launches denosumab biosimilars in US (CHF 41.73, 0.00)

• 08:28 AM ET May 23, 2025
  

  EMA's CHMP has recommended several changes to the way the antibiotic azithromycin is used in the EU, including the removal of certain indications

• 07:41 AM ET May 23, 2025
  

  EU's CHMP adopted a positive opinion recommending the granting of a marketing authorisation for (CHF 40.73, +0.46)

• 11:32 AM ET May 21, 2025
  

  Sandoz Group launches Pyzchiva autoinjector, first commercially available in Europe for ustekinumab biosimilars (CHF 40.24, 0.00)

• 11:30 AM ET May 21, 2025
  

  Sandoz launches Pyzchiva(R) autoinjector, first commercially available in Europe for ustekinumab biosimilars

• 12:12 AM ET May 20, 2025
  

  Sandoz calls on Trump to take aim at 'evergreening' pricier products to cut US drug bill - FT, citing CEO (CHF 39.18, 0.00)

• 01:17 AM ET May 02, 2025
  

  Sandoz Group upgraded to outperform from sector perform at RBC Capital Markets (CHF 35.78, 0.00)

• 05:39 PM ET Apr 30, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market